HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$6.11
Day range
$5.91 - $6.20
Year range
$1.06 - $11.88
Market cap
410.77M USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 3.04M | -19.15% |
Operating expense | 32.82M | 199.87% |
Net income | -28.36M | 18.46% |
Net profit margin | -933.23 | -0.86% |
Earnings per share | -0.38 | 46.64% |
EBITDA | -29.33M | 17.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 258.19M | -4.49% |
Total assets | 398.37M | 0.59% |
Total liabilities | 140.09M | 4.88% |
Total equity | 258.28M | — |
Shares outstanding | 68.78M | — |
Price to book | 1.63 | — |
Return on assets | -19.22% | — |
Return on capital | -23.08% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -28.36M | 18.46% |
Cash from operations | -18.12M | 45.30% |
Cash from investing | -53.40M | -199.75% |
Cash from financing | 34.58M | 5,155.99% |
Net change in cash | -36.93M | -287.26% |
Free cash flow | -9.94M | 46.71% |
About
Founded
2015
Headquarters
Website
Employees
145